Sun may end up with a Compromise!

By Hemal Shah 0

Its been a year since the Israeli Taro refused to be bought by India’s Sun Pharmaceuticals, good news may finally be coming in. It was reported that the Sun’s CEO Dilip Sanghvi and Taro chairman met at the Mediator Ram Caspi’s place.

The presence of officials from Franklin Templeton which holds over 13% stake in Taro sparks the speculation that there is a strong possibility of a price increase in Sun’s offer.

Sun had dragged Taro when it did not honour its share sale agreement.

Hemal Shah 387 posts 435 comments

Hemal is the author and curator at Indianomics. He also records and uploads videos at our YouTube channel Indianomics TV. He works and lives in Mumbai, and is a thought leader in visual design and content management. With 17+ years of experience, Hemal can help you with Digital Marketing, Content Design & Management, and Creative Visualization.

You might also like More from author

So what do you think about this article?

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More